Cerebral Venous Sinus Thrombosis
13
4
4
2
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 13 trials
100.0%
+13.5% vs benchmark
23%
3 trials in Phase 3/4
0%
0 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (13)
MENA Regional Endovascular Intervention for Venous Cerebral Venous Sinus Thrombosis
Glymphatic Function and White Matter Integrity in Cerebral Venous Disorders
The Norwegian Cerebral Venous Thrombosis Study
The Dedicated Venous Sinus Thrombectomy Stent for Endovascular Treatment of Cerebral Venous Sinus Thrombosis.
Onabotulinum Toxin A (Botox) for the Treatment of Persistent Post-Stroke and Vascular Headache
Endovascular Treatment or Standard Medical Care for Cerebral Venous Sinus Thrombosis(ESCORT)
Dabigatran Versus Rivaroxaban in Cerebral Venous Thrombosis
Dabigatran Versus Apixaban in Cerebral Venous Thrombosis
Multicenter Registry Study Of Cerebral Venous Thrombosis In China (RETAIN-CH)
Application CT and MRI in Cerebral Venous Sinus Thrombosis
The Efficacy and Safety of Batroxobin Combined With Anticoagulation in Cerebral Venous Sinus Thrombosis
Cerebral Venous Thrombosis Cohort Study in China Mainland
Cerebral Venous Sinus Thrombosis: Re-exploration of Clinical Assessment Scales